The global virology specimen collectionmarket is projected to reach USD 5.4billion by 2026 from USD 5.6billion in 2021, at a CAGR of -0.6% during the forecast period. Market growth is driven by factors such as the growth in rising number of blood donations and rising prevalence of viral diseases and emergence of newer pathogens. On the other hand, high cost of technologies and collection kits and usage of flow sensitivity screening are the major factors hampering the growth of this market.
The viral transport media segment accounted for the highest growth rate in thevirology specimen collectionmarket, by product, during the forecast period Thevirology specimen collectionmarket is segmented into test blood collection kits specimen collection tubes, swabs and viral transport media based on product.In 2020, the viral transport mediasegment accounted for the highest growth rate in the virology specimen collectionmarket.
Rising number of blood donations is the major factor contributing to the growth of this segment.
The blood samples segmentaccounted for the highest growth rate in the virology specimen collectionmarket, by sample type, during the forecast period The virology specimen collectionmarket is segmented into blood, nasopharyngeal, nasal, throat, cervical and oral based on sample type. In 2020, the blood sample segment accounted for the highest growth rate in the virology specimen collectionmarket.Rising prevalence of viral diseases and emergence of newer pathogens is themajor factor contributing to the growth of this segment.
Asia Pacific: The fastest-growing regionin virology specimen collectionmarket The global virology specimen collectionmarket is segmented into North America, Europe, the Asia Pacific and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the rising number of blood donationsare driving the growth of the virology specimen collectionmarket in this region.
The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1 - 40%, Tier 2 - 30%,and Tier 3 -30% • By Designation: C-level - 27%, D-level - 18%, and Others - 55% • By Region: North America -51%, Europe - 21%, Asia Pacific - 18% and Rest of the World – 10%
Lists of Companies Profiled in the Report: • Becton, Dickinson and Company (US) • Quidel Corporation (US) • Thermo Fisher Scientific, Inc. (US) • Trinity Biotech (Ireland) • Titan Biotech, Ltd. (India) • Diasorin SA (Italy) • Vircell S.L. (Spain) • Copan Italia S.p.A. (Italy) • Puritan Medical Products, Co. (Guilford, ME) • Hardy Diagnostics (US).
Research Coverage: This report provides a detailed picture of the global virology specimen collectionmarket.It aims at estimating the size and future growth potential of the market across different segments, such as product,sample type and region.
The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall virology specimen collectionmarket and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
Our reports have been used by over 10K customers, including:
The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high...
The soft tissue repair market is projected to reach USD 17.2Billion by 2027 from USD 13.6Billion in 2022, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by Increasing aging population and obesity rate, growing incidence of sports injuries, strong focus on R&D leading to the launch of technologically...
The autotransfusion devices market is expected to grow from US$ 1,000.26 million in 2021 to US$ 1,331.99 million by 2028; it is estimated to grow at a CAGR of 4.2% from 2021 to 2028. Rapid increase in chronic diseases, rise in transplants, and difficulty in obtaining blood groups across the globe are driving the growth of the market....
Executive Summary The global generic injectables market was valued at USD 134 billion in the year 2021 with the North American region leading the regional market share. Some of the key factors driving the generic injectables market growth are the expiration of branded drug patents, rising approvals for generic injectable...
The global depth of anesthesia monitoring market is projected to reach US$ 280.83 million by 2028 from US$ 203.32 million in 2021; it is expected to grow at a CAGR of 4.7% from 2021 to 2028. The rising number of surgical procedures drives the overall growth of the depth of anesthesia monitoring market. However, the high maintenance cost of...
The molecular quality controls market size is expected to grow from USD 164 million in 2021 to USD 226 million by 2026, at a CAGR of 6.7% during the forecast period. The growth of this market is primarily driven by factors such as the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, the...
The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...
The drug delivery devices market was valued at USD 258.81 billion in 2021, and it is expected to reach USD 394.03 billion by 2027, registering a CAGR of 7.40% during the forecast period of 2022-2027. At the outbreak of the COVID-19 pandemic, most pharmaceutical companies and governments are working toward offering efficient medical...
The global ATP assays market is projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing demand for ATP assays in pharmaceutical & biotechnology companies, rising investments in pharmaceutical & biotechnology...
The global medical radiation detection, monitoring, & safety is projected to reach USD 1.4 billion by 2027 from USD 1.0 billion in 2022, at a CAGR of 6.8% during the forecast period. Growth in this market is mainly driven by factors such as the growing geriatric population, the growing number of radio diagnostic procedures performed, therising...
Healthcare
Hospital
World
APAC
Cancer Incidence
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.